Skip to main content

Esperion Theraptc(ESPR-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Real World Data Analysis Reveals Nearly Half of All Adults at High Risk for ASCVD and Eligible for a Statin Were Not On Any Statin

Globe Newswire - Fri Jun 3, 2022

– Less than 1 in 10 were on any non-statin lipid lowering therapy –

– Findings were shared at the National Lipid Association Scientific Sessions –

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe